Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Vcanbio Cell & Gene Engineering Corp Ltd's stock price target?
Not Available
Vcanbio Cell & Gene Engineering Corp Ltd doesn't have any price targets made by Wall Street professionals.
What is Vcanbio Cell & Gene Engineering Corp Ltd's Revenue forecast?
Projected CAGR
10%
For the last 13 years the compound annual growth rate for Vcanbio Cell & Gene Engineering Corp Ltd's revenue is 15%. The projected CAGR for the next 2 years is 10%.
What is Vcanbio Cell & Gene Engineering Corp Ltd's Operating Income forecast?
Projected CAGR
31%
For the last 13 years the compound annual growth rate for Vcanbio Cell & Gene Engineering Corp Ltd's operating income is 10%. The projected CAGR for the next 2 years is 31%.
What is Vcanbio Cell & Gene Engineering Corp Ltd's Net Income forecast?
Projected CAGR
36%
For the last 13 years the compound annual growth rate for Vcanbio Cell & Gene Engineering Corp Ltd's net income is 12%. The projected CAGR for the next 2 years is 36%.
